ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,295Medicare Part D Prescriptions Filled, Including Refills

Rank: 254 out of 3001

$491K Total Retail Price of All Prescriptions

Rank: 668 out of 3001

445 Patients Receiving at Least One Drug in Part D
24%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 445 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

68% of this provider’s 445 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 2,318 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
HYDROCODONE-ACETAMINOPHEN 1,658 309 S3 1 7
AMLODIPINE BESYLATE 517 92 2 5
LISINOPRIL 427 77 3 2
ZOLPIDEM TARTRATE 414 87 4 24
OXYCODONE-ACETAMINOPHEN 397 49 S2 5 32
IBUPROFEN 380 38 6 74
PROAIR HFA 369 95 7 30
TIZANIDINE HCL 332 51 8 101
OMEPRAZOLE 320 46 9 4
TRAMADOL HCL 302 55 10 17
HYDROCHLOROTHIAZIDE 242 22 11 10
SIMVASTATIN 239 40 12 1
FUROSEMIDE 233 40 13 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 225 50 14 22
METFORMIN HCL 224 36 15 9
POTASSIUM CHLORIDE 201 48 16 15
CYCLOBENZAPRINE HCL 199 21 R 17 73
METOPROLOL TARTRATE 191 34 18 8
GABAPENTIN 185 40 19 14
ATORVASTATIN CALCIUM 128 26 20 11
NEXIUM 119 23 21 23
DIOVAN HCT 113 14 22 109
CLOPIDOGREL 110 14 23 28
PROMETHAZINE HCL 109 21 R 24 93
NAPROXEN 108 16 25 84
CARVEDILOL 106 19 26 25
TRIAMTERENE-HCTZ 101 19 27 48
MOMETASONE FUROATE 87 24 28 281
RANITIDINE HCL 84 17 29 41
FAMOTIDINE 81 19 30 68
LABETALOL HCL 80 0 31 189
SERTRALINE HCL 78 18 32 20
ADVAIR DISKUS 73 20 33 58
CLONIDINE HCL 73 23 33 64
LANTUS SOLOSTAR 72 0 35 80
FLUTICASONE PROPIONATE 65 29 36 42
AZITHROMYCIN 64 15 37 36
MUPIROCIN 61 11 38 180
SPIRIVA 57 24 39 57
LOSARTAN-HYDROCHLOROTHIAZIDE 57 0 39 49
AMITRIPTYLINE HCL 53 0 R 41 85
ACETAMINOPHEN-CODEINE 52 13 S3 42 141
VENTOLIN HFA 51 12 43 227
TRAZODONE HCL 51 0 43 37
LORAZEPAM 51 17 43 96
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 26, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.